AI Tools
Origin-1
Origin-1: Preise, Fähigkeiten, Updates und Alternativen, von den Seiten des Anbieters gelesen.

Auf Englisch
Key facts
- Price
- Not stated on the maker’s pages
- Free plan
- Not stated on the maker’s pages
- Platforms
- Not stated on the maker’s pages
- API
- Not stated on the maker’s pages
- Open source
- Yes · MIT Read on github.com
Origin-1 designs monoclonal antibodies for “zero-prior” epitopes—target sites without reported structures of antibody or other protein binders. Absci describes a workflow that generates antibody structures and sequences, then scores and filters candidates. It is intended for therapeutic discovery and lead identification.
The system combines AbsciDiff for structure generation, IgDesign2 for antibody sequence design, and AbsciBind for candidate scoring. Absci reports validation with laboratory assays; generated designs are candidates, not experimentally confirmed results by themselves. The public repository contains study data and model artifacts, but Absci’s site does not list commercial access terms or prices.
- Category
- Research & Education
- Read from the maker’s pages
- 2026-11-18
Company
Features
- Generates antibody–antigen structures conditioned on antigen structure and user-defined epitopes.
- Designs all six antibody complementarity-determining regions.
- Models heavy- and light-chain sequence design together.
- Scores and filters antibody candidates before experimental testing.
- Includes a public repository of study data and model artifacts under the MIT license.
- Reports validation using SPR, BLI, size-exclusion chromatography, and developability screening.
Use cases
- Design antibody candidates for target sites without known protein binders.
- Explore epitope-specific binders for targets lacking solved complex structures.
- Rank and filter antibody designs before laboratory testing.
- Prioritize antibody candidates for specificity and developability assays.
- Use published model artifacts and study data to examine reported designs.
Questions about Origin-1
Is Origin-1 open source?
Yes. The code of Origin-1 is published at github.com/AbSciBio/origin-1 under the MIT licence. Read on the maker’s pages on 18 Nov 2026.
Is Origin-1 still available?
Yes, as of 18 Nov 2026: its maker’s pages were read that day and carried no notice that Origin-1 has ended.
Sources
- https://www.absci.com/denovo/ — Official product description, design workflow, model components, and validation methods.
- https://www.absci.com/blog/ — Official blog checked for a newer Origin-1 announcement; no posts were displayed.
- https://www.absci.com/ — Absci homepage reviewed; no Origin-1 pricing page was identified.
- https://github.com/AbSciBio/origin-1 — Maker’s public repository describes included study data and model artifacts and identifies an MIT license.
- https://www.biorxiv.org/content/10.64898/2026.01.14.699389v1 — Origin-1 technical preprint and its posting date.
Not confirmed
- Prices
- No official Origin-1 pricing page was found in the search or Absci pages reviewed.
- No official pricing page with readable prices was found.
- No official price was found.
- Free plan
- The pages reviewed do not state whether commercial access has a free tier.
- API
- The product and repository pages reviewed do not confirm an API.
- Platforms
- The pages reviewed do not specify end-user software platforms.
- Latest version
- No separate current product version or model version was stated.